DSN Breaks Down the Brands and Categories Driving the Business

A DSN Special Report OTC BUYERS GUIDE DSN breaks down the brands and categories driving the business.

table of contents

Baby boomers, prevention drive OTC ...... 20 Rx-to-OTC switch ...... 22 Q&A: The future of OTC ...... 22 Cough-cold, allergy & sinus ...... 24 Diagnostics ...... 26 Digestives ...... 28 Ear & eye care ...... 30 Pain relief ...... 32 Vitamins, minerals & supplements ...... 34 Sleep remedies ...... 36 Smoking cessation ...... 38 Weight loss ...... 40 Products ...... 42

DrugStoreNews.com march 17, 2014 • 19 OTC Buyer’s guide

Baby boomers, preventive solutions drive OTC

Section by Michael Johnsen over-the-counter market* 9 Total = $40.2 billion intimacy health Overall, the OTC sector in 2013 realized $0.9/2.2% $40.2 billion in sales, according to data culled smoking cessation 10 $0.9/2.2% feminine care from OTC categories tracked by IRI. That’s foot care $0.5/1.2% $1.0/2.5% up from the $38.3 billion that DSN reported sleeping remedies 8 last year. The 2013 sales numbers reflect a diagnostics $0.4/1.0% $1.0/2.5% strong 2012-2013 cough-cold season and the misc. health Cough/cold/ relaunch of Tylenol, Excedrin and Motrin. remedies7 allergy/sinus1 The aging of the baby boomer is reflected $1.5/3.7% $7.7/19.2% across the best-selling OTC brands. Two of the top five brands are pain relievers. The eye care/ adult incontinence brand Poise holds the No. ear care6 2 spot in terms of OTC sales, and standing at $1.9/4.7% No. 6 is Ensure’s RTD protein shakes. vitamins While baby boomers will continue to drive first aid5 $6.5/16.2% the pound of cure, overall more Americans $2.8/7.0% are more often seeking their ounce of prevention. According to Bain & Co.’s recent Healthy Living Survey, 75% of consumers are in pursuit of a healthier lifestyle. Take 4 weight loss/ that predominant mindset, coupled with the pain relief $4.4/10.9% nutritional meal 2 outcomes-driven preventive focus associated digestives3 replacements with the Affordable Care Act, and you have a $5.3/13.2% $5.4/13.4% formula for OTC success at retail pharmacy. *In billions; percent reflects share of total OTC/natural health segments Retailers are already supplying preven- Source: IRI for Total U.S. Multi-Outlet (supermarkets, drug, mass, military commissary, and select club and dollar stores) for the 52 weeks tive health solutions. H-E-B and Rediclinic ended Dec. 29, 2013 1 Includes hand sanitizer, chest rubs, humidifiers, cold/allergy/sinus liquids, cough drops, cough syrup, nasal products, and cold/allergy/ last month augmented its Weigh Forward sinus tablets. 2 Includes weight control/nutrition liquid/powder, weight control candy/tablets, energy shots, and nutritional/intrinsic health weight-loss clinic with an online compo- value bars. 3 Includes motion sickness, gastrointestinal tablets, gastrointestinal liquids, and adult incontinence. 4 Includes external analgesic rubs, internal analgesics, and heat/ice packs. 5 Includes first aid tape/bandage/gauze, first aid kits, muscle/body support devices nent. Also, GlaxoSmithKline and Walgreens and first aid treatment. 6 Includes ear care products and ear drops/treatments, as well as eye/contact lens care products. 7 Includes hemorrhoidal cream/ointment/spray, hemorrhoidal remedies, lip treatment, caffeine tablets/liquids, epsom salts, lice treatments and wart teamed up to launch Sponsorship to Quit, a removers. 8 Includes home health care/kits and family planning. 9 Includes sexual health and personal lubricants. 10 Includes vaginal free online quit-smoking program. treatments and all other feminine hygiene/medical treatments.

Top 10 otc Brands

Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Units* % Unit Chg Avg Price Avg Price Chg Advil / internal analgesic tablets $490.9 -0.6% 15.6% -0.5% 66.6 -2.4% $7.37 $0.14 Poise / adult incontinence products 379.1 7.3 26.7 0.3 46.8 3.4 8.11 0.29 Merck & Co. / foot care devices (Dr. Scholl's) 369.9 2.0 54.6 0.3 38.3 -1.7 9.66 0.35 Aleve / internal analgesic tablets 364.0 2.4 11.6 0.0 48.4 -5.2 7.52 0.56 Prilosec OTC / antacid tablets 358.8 -10.4 18.2 -1.9 20.0 -9.7 17.98 -0.13 Ensure / weight-control/nutritionals liquid/powder 343.5 6.5 13.2 0.1 33.6 0.0 10.23 0.62 Depend / adult incontinence products 341.1 0.2 24.0 -1.4 23.1 -5.3 14.78 0.81 5 Hour Energy / single-serve energy shot 331.6 -11.8 85.7 -0.3 58.5 -9.1 5.66 -0.17 Zyrtec / cold-allergy-sinus tablets/packets 317.3 1.8 7.5 -0.2 16.9 2.0 18.72 -0.04 General Mills Fiber One / nutritional/intrinsic health value bars 305.4 25.2 15.7 1.5 84.7 27.8 3.60 -0.08

* In millions Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. Multi-Outlet (supermarkets, ** Percent share of segment drug stores, mass market retailers, military commissaries and select club and dollar retail chains)

20 • march 17, 2014 DrugStoreNews.com OTC Buyer’s guide FDA makes unprecedented Rx-to-OTC switches Two Rx-to-OTC switches in the past really a first for the FDA,” said Mackey, projected rx-to-otc candidates year may serve as a harbinger of what who also is chairman of the Consum- the Food and Drug Administration er Healthcare Products Association. Brand Class Company will consider “switch” worthy. They “We’re very favorably disposed to the AcipHex PPI Eisai both address chronic care needs, and direction that the FDA is following, Actonel Osteoporosis Warner Chilcott they both represent first of their kind and we [as an industry] are very inter- medicines to the nonprescription aisle. ested in working with them to enable Boniva Osteoporosis Genentech The first of the two is Merck Con- more novel switches in the future.” Cialis ED Lilly USA sumer Care’s Oxytrol for Women, “[All told], Rx-to-OTC switches Clarinex Allergy Merck a thin, flexible patch for the relief of are expected to continue, with more Crestor Statin AstraZeneca overactive bladder in women. It is the than $10 billion in branded prescrip- first and only over-the-counter option tion sales likely to switch in the next Detrol LA Overactive bladder Pfizer that treats OAB symptoms, including five years,” said Joseph Papa, Perrigo Ditropan Overactive bladder Janssen Pharmaceuticals urinary incontinence, urgency and fre- chairman, CEO and president. Evista Osteoporosis Lilly USA quency. With 20 million OAB sufferers, Much of that includes other medi- Fosamax Osteoporosis Merck sales of Oxytrol are projected to reach cines in the respective classes of Oxytrol as high as $50 million. (e.g., Pfizer’s Detrol LA) and Nasacort Imitrex Migraine GlaxoSmithKline The second is Chattem’s Nasacort (e.g., Merck’s Nasonex). Pfizer is expect- Lescol Statin Novartis Allergy 24HR — the first and only ed to bring the proton-pump inhibitor Levitra ED Bayer/GlaxoSmithKline nasal corticosteroid on OTC shelves. Nexium and its $2.1 billion volume in Lipitor Statin Pfizer Kline Healthcare’s industry analyst prescription dollars over-the-counter Laura Mahecha projected Nasacort Al- this spring, if not later this year. Nasonex Allergy/corticosteroid Merck lergy’s annual sales potential to reach Statins, such as Pfizer’s Lipitor, also Nexium PPI Pfizer remain speculative switch potentials as high as $200 million. Pravachol Statin BMS “You are seeing a new openness, despite the FDA having denied statin I think, on the part of the FDA to the switches in the past. To date, no switch Propecia Male pattern baldness Merck switching of products that maybe here- application has taken advantage of Protonix PPI Pfizer tofore wouldn’t have been considered the FDA’s Nonprescription Drug Safe Viagra ED Pfizer for switch,” Jim Mackey, Merck Con- Use Regulatory Expansion that opens Vytorin Statin Merck sumer Care SVP, U.S. region head, told the door to utilizing healthcare profes- DSN. “[Oxytrol] is the type of product sionals and technology in expanding Zetia Statin Merck — treating a chronic condition — that is the FDA’s conditions of safe use. Source: DSN research

that there will be opportunities this year to enact the legislation in the fall.

Jim Mackey: We have a huge opportunity in this time of massive change Q&A to better position OTC medicines as that critical first-line treatment in the The future of OTC overall healthcare continuum.

Scott Melville & Jim Mackey DSN: What are the key opportunities for the OTC industry? Consumer Healthcare Products Association Mackey: We see many … opportunities on the forefront where consumers In advance of CHPA’s 2014 Annual Executive Conference, DSN sat can responsibly treat chronic conditions with over-the-counter medicines. down with Scott Melville, CHPA president and CEO, and Jim Mackey, We’re very favorably disposed to the direction that the FDA is following. CHPA chairman, to discuss what’s in store for the OTC industry. Melville: The association under the board’s leadership … is undertaking DSN: Is there progress in making OTCs eligible for FSAs? a very exciting research project on consumer insights [concerning] over- the-counter medicines. … We’re doing some quantitative and qualitative Scott Melville: There’s legislation introduced in the House and the Senate. research that we will be releasing later this year. … Given that the budget stalemate is behind us and President Obama has conceded that improvements to ACA are necessary, … we’re hopeful For the complete Q&A, visit drugstorenews.com/audio

22 • march 17, 2014 DrugStoreNews.com OTC Buyer’s guide

Cough-Cold, Allergy & sinus Remedy sales up in less robust season Though the 2013-2014 cough-cold and flu season has been charac- by the channel terized as less robust as compared with a year ago, sales of cold and allergy remedies still are up significantly. According to IRI, sales of Multi-Outlet* % Chg Drug % Chg cold and allergy tablets were up 4.5% to $4.2 billion, while liquids Cold/allergy/sinus tablets $4,240.0 4.5% $1,906.4 3.0% were up 10% to $1.1 billion. Cold/allergy/sinus liquids 1,087.8 10.0 456.5 9.0 According to Hyland’s EVP Les Hamilton, sales of flu relief Nasal products 677.9 2.0 326.2 3.5 and multisymptom solutions have been trending particularly well this season. Cough drops 589.3 10.2 234.7 9.3 Granted, those sales include the latter half of last year’s strong Cough syrup 515.9 6.2 253.9 4.9 cough-cold season, but there were several new product launches that Humidifiers 283.3 9.3 61.7 8.5 helped boost growth as well, such as Bayer’s new Alka Seltzer Plus and Reckitt Benckiser’s Mucinex Fast Max line extension. Also mak- Hand sanitizer 191.7 7.8 38.0 9.5 ing a return to shelves was McNeil’s allergy mainstay Benadryl. Chest rubs 89.6 8.4 38.6 6.3 And launching just last month is Chattem’s Nasacort Allergy 24HR Total $7,675.5 NA $3,316.0 NA nasal spray, the first nasal corticosteroid to reach the market. Analysts * Supermarkets, drug stores, mass market retailers, military commissaries and select club peg Nasacort’s annual market potential at $200 million, which will and dollar retail chains place that brand in the top 10 of cough-cold and allergy products. Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions. Top 20 Brands† Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Units* % Unit Chg GoGargle! Zyrtec / tablets/packets $317.3 1.8% 7.5% -0.2% 16.9 2.0% Mondelez International (Halls) / cough/sore throat drops 263.2 7.7 44.8 -1.0 137.9 2.7 a hit at ECRM Claritin / tablets/packets 214.1 6.6 5.1 0.1 13.3 -0.3 O’Connor Cos.’ new Allegra / tablets/packets 203.1 -7.6 4.8 -0.6 11.7 -10.5 product GoGargle! was Alka Seltzer Plus / tablets/packets 188.7 21.8 4.5 0.6 31.5 20.5 named Best New Product Mucinex DM / tablets/packets 166.7 -9.7 3.9 -0.6 10.8 -10.3 last month at the ECRM Cough/Cold, Analgesics Vicks NyQuil / liquid/powder 158.0 8.4 14.5 -0.2 18.6 0.7 & Allergy meeting in Ame- Reckitt Benckiser (Delsym) / cough syrup 149.6 3.4 31.8 -0.9 13.2 0.3 lia Island, Fla. GoGargle! is Mucinex / tablets/packets 145.1 -11.5 3.4 -0.6 8.9 -13.1 an effervescent salt gargle Claritin D / tablets/packets 144.1 2.5 3.4 -0.1 7.7 3.5 that soothes and moisturiz- Ricola / cough/sore throat drop 115.4 14.0 19.6 0.7 50.5 9.6 es dry and irritated throats in a new way. Benadryl / tablets/packets 104.5 23.6 2.5 0.4 17.9 12.3 GoGargle! combines salt Kaz Vicks / humidifiers/vaporizers/air purifier-filter 97.4 -0.9 34.3 -3.6 5.5 -1.2 with honey, zinc, chamo- Mucinex Fast Max / liquid/powder 95.3 25.5 8.8 1.1 7.5 13.7 mile, aloe and 10 vitamins Allegra D / tablets/packets 94.2 3.4 2.2 0.0 4.6 0.3 a n d herbs. Pfizer (Robitussin) / cough syrup 93.7 9.2 19.9 0.5 13.4 8.1 Mucinex D / tablets/packets 90.8 -9.5 2.1 -0.3 4.5 -10.3 Breathe Right / nasal strips 89.7 -15.4 75.3 -8.2 9.7 -17.4 Mucinex Fast Max / tablets/packets 79.6 157.6 1.9 1.1 6.0 157.1 Claritin RediTabs / tablets/packets 72.1 1.6 1.7 -0.1 4.9 -4.1

* In millions Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. Multi-Outlet † Includes hand sanitizer, chest rubs, humidifiers, cold/allergy/sinus liq- (supermarkets, drug stores, mass market retailers, military commissaries and uids, cough drops, cough syrup, nasal products, cold/allergy/sinus tablets select club and dollar retail chains) ** Percent share of segment

24 • march 17, 2014 DrugStoreNews.com OTC Buyer’s guide

Diagnostics Wireless solutions future for industry Diagnostics will help augment the goal-oriented disease-state by the channel management programs being implemented by retail pharmacies. And while wireless solutions will help lead the way, the industry Multi-Outlet* % Chg Drug % Chg isn’t there. Yet. Glucose monitors $307.7 0.2% $147.6 -5.5% The introduction of wireless fitness devices over the past year will help Pregnancy test kits 306.2 3.0 157.3 1.0 pave the way to consumer adoption of more advanced blood-pressure monitors and glucose meters. This past fall, Walgreens folded into its pla- Blood-pressure kit 201.0 -0.4 118.5 -0.2 nogram a set titled “Wireless ways to wellness” that featured app-friendly, Other home testing kits 91.1 24.2 70.3 25.9 wireless fitness devices. “Fitness devices will be [adopted] the fastest Testing accessories 45.3 2.2 33.1 -0.4 because they have the most active, computer-savvy [technicians] work- Ovulation prediction kits 44.0 4.1 21.5 2.9 ing with them,” remarked Ranndy Kellogg, Omron Healthcare COO. “Other devices like glucose [and] blood-pressure monitors are heading Lancet/device 22.2 3.1 15.8 3.4 there, but nowhere near as fast as the fitness products.” Urine tests/kits 11.4 16.2 8.6 19.0 There also is future growth potential in diagnostic devices that Total $1,028.9 NA $572.7 NA capture health data not before seen in the self-care environment. Ora- * Supermarkets, drug stores, mass market retailers, military commissaries and select club sure Technologies’ OraQuick In-Home HIV test, for example, detects and dollar retail chains antibodies to both HIV-1 and HIV-2 with an oral swab. Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions Top 20 Brands†

Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Units* % Unit Chg Bayer’s USB First Response / pregnancy test kits $81.5 6.6% 26.6% 0.9% 6.2 6.5% diabetes system Omron / blood-pressure kit 73.6 -1.5 36.6 -0.4 1.3 -0.4 gains sales LifeScan One Touch Ultra / glucose 52.9 -15.4 17.2 -3.2 0.9 -18.9 Clearblue / pregnancy test kits 46.3 18.3 15.1 2.0 3.7 14.8 Bayer’s Contour Next has captured $8.4 million e.p.t / pregnancy test kits 34.9 -9.2 11.4 -1.5 2.4 -7.7 in sales in a little more First Check / other home testing kits 32.1 8.2 35.2 -5.2 1.5 8.3 than one year on shelf, At Home / other home testing kits 22.8 -1.2 25.0 -6.4 1.0 -2.7 according to IRI. The BD Ultra Fine / testing accessories 20.8 -1.6 45.9 -1.7 2.0 5.3 USB glucose-testing system provides innovative Clearblue / ovulation prediction kits 21.2 32.8 48.3 10.4 0.5 32.4 technology for enhanced Freestyle Lite / glucose 19.7 -5.7 6.4 -0.4 0.4 -11.6 accuracy by combining Bayer Contour / glucose 18.9 -11.6 6.2 -0.8 0.4 5.6 a next-generation test Accu Chek Aviva Plus / glucose 17.0 -2.9 5.5 -0.2 0.4 -8.5 strip with an algorithm, multipulse technology First Response Rapid Result / pregnancy test kits 8.7 17.0 2.8 0.3 0.6 16.1 and a proprietary Oraquick / other home testing kits 8.7 698.4 9.5 8.1 0.2 697.6 mediator. Bayer Contour Next / glucose 8.4 NA 2.7 2.5 0.3 NA First Response / ovulation prediction kits 7.9 -7.7 18.0 -2.3 0.3 -2.2 Answer / pregnancy test kits 7.8 -36.4 2.6 -1.6 0.9 -33.3 Accu Check Compact / glucose 6.8 -25.6 2.2 -0.8 0.1 -30.6 First Response Gold / pregnancy test kits 5.9 -2.6 1.9 -0.1 0.3 -7.0 Sidekick / glucose 5.4 -4.5 1.8 -0.1 0.3 -4.5

* In millions Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. Multi-Outlet (supermarkets, † Includes home health care/kits and family planning drug stores, mass market retailers, military commissaries and select club and dollar retail chains) ** Percent share of segment

26 • march 17, 2014 DrugStoreNews.com OTC Buyer’s guide

Digestives Reintros, switch to boost stomach remedies Overall, digestive sales were relatively flat in 2013. But that will not be by the channel the case in the coming year — not with a pair of brand reintroductions and a possible switch in the category. Imodium is experiencing a resur- Multi-Outlet* % Chg Drug % Chg gence with its return to the shelves, banking $82.5 million in total U.S. Antacid tablets $1,966.1 -1.0% $658.0 -1.9% multi-outlet sales last year, according to IRI. And Chattem is bringing the Adult incontinence 1,419.1 6.0 443.2 3.7 venerable Rolaids brand back into the digestives fold. Laxative tablets 671.9 -0.8 299.5 -1.6 Then there’s the possible switch of Nexium into OTC aisles, which Laxative/stimulant liq/pwdr/oil 609.7 -1.4 227.5 -4.6 will bring a $2.1 billion volume in prescriptions over the counter, and po- tentially will make Pfizer’s proton-pump inhibitor the next $200 million Diarrhea tablets 178.1 1.1 75.3 -3.5 antacid brand. Of all the antacids, Tums and Rolaids are best equipped Stomach remedy liq/pwdr 176.9 -1.5 61.8 -1.9 to handle a Nexium introduction. The brands are cheaper than their H2- Antacid liq/pwdr 94.1 0.5 41.3 3.3 blocker and PPI cousins and provide more immediate relief. That may Antacid/analgesic combo tablets 58.6 -1.8 17.4 0.3 explain why other marketers are moving into that tried-but-true calcium Stomach remedy tablets 53.7 10.8 21.4 16.4 carbonate space. Bayer Consumer last year launched Alka Seltzer Fruit Chews, for example. Diarrhea medicine liq/pwdr 38.4 18.1 20.1 13.5 The aging of the baby boomers has brought incontinence products to Motion sickness 16.1 8.0 10.0 6.7 the forefront. Poise generated $379.1 million in sales on 7.3% growth. And Total $5,282.7 NA $1,875.5 NA

Merck’s introduction of a new-to-self-care overactive bladder indication * Supermarkets, drug stores, mass market retailers, military commissaries, select club and dollar with Oxytrol has a sales potential of $50 million in incremental dollars. retail chains Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions Top 20 Brands† Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Units* % Unit Chg Rolaids to Poise / adult incontinence products $379.1 7.3% 26.7% 0.3% 46.8 3.4% relaunch Prilosec OTC / antacid tablets 358.8 -10.4 18.2 -1.9 20.0 -9.7 Depend / adult incontinence products 341.1 0.2 24.0 -1.4 23.1 -5.3 Chattem last fall un- Miralax / laxatives/stimulant liquid/powder/oil 179.4 -2.7 29.4 -0.4 13.6 -2.2 veiled its plans to reintro- Zantac 150 / antacid tablets 114.2 4.5 5.8 0.3 10.4 2.0 duce the iconic Rolaids Metamucil / laxatives/stimulant liquid/powder/oil 109.0 -5.7 17.9 -0.8 8.1 -9.9 heartburn-relief brand, absent on U.S. market Dulcolax / laxative tablets 105.2 2.3 15.7 0.5 15.1 -0.5 shelves for the past three Prevacid 24HR / antacid tablets 92.9 -23.0 4.7 -1.4 4.9 -20.5 years. Chattem will sup- Pepto Bismol / stomach remedy liquid/powder 82.6 0.2 46.6 0.8 16.1 -0.2 port the relaunch of Ro- Imodium / diarrhea tablets 82.5 97.1 46.2 22.5 8.5 84.9 laids with a fully integrat- Gas X / antacid tablets 67.9 5.2 3.5 0.2 10.7 4.9 ed marketing campaign Tums / antacid tablets 66.2 -5.1 3.4 -0.2 17.0 -8.0 featuring chef and restau- Tums Ultra / antacid tablets 62.2 3.8 3.2 0.1 12.5 1.7 rateur Guy Fieri. Serenity Tena / adult incontinence products 62.1 -14.2 4.4 -1.0 5.9 -24.6 Depend Silhouette / adult incontinence products 51.7 63.2 3.6 1.3 4.2 30.7 Pepcid AC / antacid tablets 51.5 -5.3 2.6 -0.1 4.5 -14.2 Alka Seltzer / antacid/analgesic combo 47.5 -1.7 81.0 0.0 9.7 -4.2 Serenity Tena Odasorb Plus / adult incontinence 46.8 -2.7 3.3 -0.3 3.9 -13.8 Tums Ex / antacid tablets 43.2 -10.3 2.2 -0.2 14.7 -9.2 Phillips / stomach remedy liquid/powder 39.2 -4.5 22.1 -0.7 7.0 -4.8

* In millions Source: IRI for the 52 weeks ended Dec. 29, 2013, † Includes motion sickness, gastrointestinal tablets, gastrointestinal liquids and adult incontinence Total U.S. Multi-Outlet (supermarkets, drug stores, ** Percent share change mass market retailers, military commissaries and select club and dollar retail chains)

28 • march 17, 2014 DrugStoreNews.com OTC Buyer’s guide

Eye & Ear care Comfort cleans up across category The vast majority of eye care professionals reported using chemi- by the channel cal care systems (76%) with contact lens patients, followed by hydrogen peroxide-based systems (24%), according to a survey conducted Multi-Outlet* % Chg Drug % Chg by Contact Lense Spectrum that was published in January. Eye/lens care solutions $1,584.3 1.8% $574.8 3.0% According to the survey, 85% of eye care professionals are recom- Eye/lens care tablets/ 103.4 12.9 38.7 -2.9 mending specific brands of contact lens care systems to their patients. accessories “The most significant factors in determining the selected recommen- Ear care products 92.7 31.0 47.5 29.2 dation was improved comfort (27%), followed closely by lens mate- rial/solution compatibility (26%), and then cleaning efficacy (19%), Ear drops/treatments 73.9 3.6 44.2 5.2 disinfectant efficacy (18%), convenience (8%) and cost (2%),” wrote Total $1,854.3 NA $705.2 NA Jason Nichols in the annual eye care report. One of the breakthrough products in ear care over the past year * Supermarkets, drug stores, mass market retailers, military commissaries and select club and dollar retail chains has been the As Seen on TV WaxVac “ear cleaner.” It’s the leading ear Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions care SKU with $19.1 million in sales. The ear plug sector has become segmented across several use opportunities — swim, sleep, air travel fied more needs for ear care,” said Lanny Lewis, SVP Cirrus Healthcare and noise reduction — which is creating incremental purchases within Products. “One of the initiatives we’ve done successfully in the past year the category. “The business has evolved as customers have identi- — we’ve licensed [our silicone ear plugs] in the children’s space.” Top 20 Brands† Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Units* % Unit Chg AquaEars Alcon Opti-Free Replenish / eye/lens care solutions $145.3 -12.3% 9.2% -1.5% 14.6 -15.8% feature Ciba Vision Clear Care / eye/lens care solutions 107.3 1.3 6.8 0.0 8.8 -0.7 characters Alcon Opti-Free Pure Moist / eye/lens care solutions 82.2 30.9 5.2 1.2 9.0 23.1 Alcon Systane Ultra / eye/lens care solutions 66.1 9.8 4.2 0.3 5.1 5.2 Cirrus Healthcare Prod- Alcon Systane / eye/lens care solutions 61.9 7.5 3.9 0.2 4.5 3.0 ucts last year launched a new line of AquaEars fea- Bausch & Lomb Biotrue / eye/lens care solutions 60.4 23.8 3.8 0.7 7.0 28.3 turing a variety of licensed Bausch & Lomb Renu Fresh / eye/lens care solutions 56.2 1.7 3.6 0.0 9.3 4.5 characters, including Clear Eyes / eye/lens care solutions 50.7 3.8 3.2 0.1 12.1 0.9 SpongeBob SquarePants, Alcon Opti-Free Express / eye/lens care solutions 46.7 -9.2 3.0 -0.4 4.5 -13.1 Dora the Explorer, Disney Allergan Refresh Tears / eye/lens care solutions 35.8 7.5 2.3 0.1 2.8 4.2 and Hello Kitty. The ever- green licenses help differ- Allergan Refresh Optive / eye/lens care solutions 33.0 4.8 2.1 0.1 2.4 -4.2 entiate the products from Allergan Refresh Plus / eye/lens care solutions 28.6 4.6 1.8 0.1 1.9 -0.8 store-brand options and Genteal / eye/lens care solutions 28.6 -1.9 1.8 -0.1 2.4 -10.0 improve proper use of the Thera Tears / eye/lens care solutions 26.0 16.5 1.6 0.2 2.5 18.5 earplugs among children. Alcon Systane Balance / eye/lens care solutions 24.0 21.9 1.5 0.3 1.7 16.9 Zeiss / eye/lens care tablets/accessories 22.6 69.6 21.8 7.3 4.9 126.8 Alcon Zaditor / eye/lens care solutions 20.7 97.8 1.3 0.6 1.4 92.0 Bausch & Lomb Opcon A / eye/lens care solutions 19.8 2.8 1.3 0.0 2.6 3.6 WaxVac / ear care products 19.1 NA 20.6 20.6 1.9 NA Bausch & Lomb Advanced Eye Relief / 18.0 -1.6 1.1 0.0 3.6 -1.2 eye/lens care solutions

* In millions ** Percent share of segment Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. Multi- † Includes ear care products and ear drops/treatments, and eye/contact lens Outlet (supermarkets, drug stores, mass market retailers, military care products commissaries and select club and dollar retail chains)

30 • march 17, 2014 DrugStoreNews.com OTC Buyer’s guide

Pain relief Return of big brands brings relief To date, the return of mega brands like McNeil’s Tylenol and Motrin by the channel and Novartis’ Excedrin have helped lift overall category sales. According to IRI, sales of analgesic liquids were up 5.6% to $390.3 million across total Multi-Outlet* % Chg Drug % Chg U.S. multi-outlets, while pain relief tablets were up 2.5% to $3.1 billion. Internal analgesic tablets $3,145.6 2.5% $1,073.1 -0.4% “[Retailers] are reacting to [the returning brands] almost as if they are new External analgesic rubs 475.5 7.3 229.3 4.7 launches,” Stefan Merlo, director of healthcare strategy at Novartis Con- sumer Healthcare, told DSN in the fall. “And they are investing [with us] Internal analgesic liquids 390.3 5.6 168.2 1.5 in different types of displays, innovative types of [displays], so that we Heat/ice packs 238.7 1.5 129.7 -2.4 can make the awareness about these brands even greater.” Feminine pain relievers 102.4 25.6 40.0 25.4 Advertising campaigns are working at successfully recapturing sales Total $4,352.5 NA $1,640.3 NA ceded to private label because sales of store-brand equivalents, even in this still-tough economy, are down. Analgesic liquid private label was * Supermarkets, drug stores, mass market retailers, military commissaries and select club down 5.7%, while tablets were down 3.8% last year. More telling: While and dollar retail chains Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions sales of tablets are up, units sold are down 1.1%, suggesting Americans aren’t buying more pain relief, they’re just spending more. Units sold One trend worth watching is pain relief in liquid shot format. Prestige across liquids were up 3%, but that includes pediatric fever reducers that Brands was the first to adopt an “energy shot” format for pain relief. GM may have gotten a boost from the strong 2012-2013 cough-cold season. Pharmaceuticals has followed with VanaPain and VanaPain PM. Top 20 Brands† Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Units* % Unit Chg Shot format Advil / internal analgesic tablets $490.9 -0.6% 15.6% -0.5% 66.6 -2.4% brings faster Aleve / internal analgesic tablets 364.0 2.4 11.6 0.0 48.4 -5.2 pain relief Bayer / internal analgesic tablets 222.4 3.1 7.1 0.0 38.9 0.7 Tylenol / internal analgesic tablets 200.1 39.9 6.4 1.7 29.6 35.0 Consumers are already familiar with the energy Icy Hot / external analgesics rubs 110.3 6.0 23.2 -0.3 18.8 4.7 shot, and now companies Advil PM / internal analgesic tablets 90.2 3.0 2.9 0.0 11.4 0.3 like GM Pharmaceuticals Excedrin Migraine / internal analgesic tablets 76.0 284.7 2.4 1.8 11.2 320.0 are introducing that kind of Thermacare / heat/ice packs 61.8 -3.0 25.9 -1.2 9.6 -8.6 innovation into the pain relief category with products Excedrin / internal analgesic tablets 54.9 NA 1.7 1.7 7.8 NA like VanaPain. The other Children’s Tylenol / internal analgesic liquids 51.4 7.9 13.2 0.3 7.8 5.3 differentiator is VanaPain’s Motrin IB / internal analgesic tablets 48.0 23.9 1.5 0.3 5.1 29.0 active ingredient choline Children’s Motrin / internal analgesic liquids 47.6 203.6 12.2 7.9 7.2 206.6 salicylate; in liquid form, it has an onset of action Salonpas / external analgesics rubs 47.3 32.3 9.9 1.9 12.6 20.6 that works five times faster Bengay / external analgesics rubs 46.1 1.5 9.7 -0.6 7.3 3.6 than aspirin. Midol / feminine pain relievers 45.0 -4.0 43.9 -13.6 7.3 -4.3 BC / internal analgesic tablets 41.8 3.8 1.3 0.0 10.9 2.8 Goody’s / internal analgesic tablets 37.3 1.9 1.2 0.0 9.9 -5.7 Children’s Advil / internal analgesic liquids 34.0 -16.0 8.7 -2.3 5.8 -14.1 Aspercreme / external analgesics rubs 33.1 3.9 7.0 -0.2 6.6 6.0 Azo Standard / internal analgesic tablets 27.9 16.8 0.9 0.1 4.0 14.1

* In millions Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. † Includes external analgesic rubs, internal analgesics and heat/ice packs Multi-Outlet (supermarkets, drug stores, mass market retailers, ** Percent share of segment military commissaries and select club and dollar retail chains)

32 • march 17, 2014 DrugStoreNews.com OTC Buyer’s guide

Vitamins, minerals & Supplements Gummys stick with vitamin growth Vitamins, minerals and supplements is one of the categories that can by the channel help link retail pharmacy initiatives to the kind of positive outcomes pay- ers will be looking for with the Affordable Care Act. A recent Frost & Sul- Multi-Outlet* % Chg Drug % Chg livan report determined that supplementation at preventive intake levels Mineral supplements $3,322.4 2.6% $1,255.1 1.8% in high-risk populations can reduce the number of medical events associ- Multivitamins 1,730.2 6.2 520.6 7.2 ated with heart disease, age-related eye disease, diabetes and bone disease in the United States, representing the potential for significant cost savings. 1 & 2 Letter vitamins 1,044.5 5.4 381.9 7.1 The gummy delivery form of vitamins are the single-largest source of Liquid vitamins/minerals 384.7 12.2 127.8 15.6 growth for the category, Pharmavite spokesman Doug Jones told DSN re- Total $6,481.8 NA $2,285.4 NA cently. “Within the gummy delivery form, 65% of the sales are now repre- * Supermarkets, drug stores, mass market retailers, military commissaries and select club sented by the adult life stage products and only 35% are children-based.” and dollar retail chains Citing internal figures, Jones noted that adult gummy sales have increased Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions 51% in the past year, while children’s gummys have been relatively flat. “Our gummy vitamin sales are growing at a 20% rate to approxi- adults switch from traditional vitamin pills to gummy vitamins.” mately $300 million in annual net sales in 2013,” James Craigie, Church Other product segments that are contributing large-scale growth to the cat- & Dwight chairman and CEO, told analysts in December. “We believe egory are gender-specific multivitamins, biotin, melatonin, Co-Q10, vitamin the future prospects of the gummy vitamin category are strong as more D, vitamin B-12 and vision formula multivitamins, Jones said.

Top 20 brands† Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Units* % Unit Chg Pharmavite Nature Made / mineral supplements $303.1 1.3% 9.1% -0.1% 31.9 -0.6% expands adult Nature Made / 1 & 2 letter vitamins 293.4 6.2 28.1 0.2 36.2 2.3 Nature’s Bounty / mineral supplements 280.6 0.7 8.4 -0.2 31.9 -0.1 gummies line Centrum Silver / multivitamins 201.0 3.4 11.6 -0.3 16.3 4.6 Category leader Phar- Nature’s Bounty / 1 & 2 letter vitamins 127.3 13.6 12.2 0.9 15.2 8.5 mavite has a knack for Airborne / multivitamins 110.5 24.5 6.4 0.9 15.1 20.4 identifying a consumer Emergen-C / liquid vitamins/minerals 108.4 22.7 28.2 2.4 13.2 23.6 need and fulfilling that Sundown Naturals / mineral supplements 101.1 11.6 3.0 0.3 13.9 9.7 need with new product of- Osteo Bi Flex 5 Loxin Advanced / ferings, as evidenced by 101.0 30.6 3.0 0.7 5.2 30.2 mineral supplements some $600 million in VMS sales. Capitalizing on the Schiff Mega Red / mineral supplements 92.4 16.6 2.8 0.3 4.2 13.5 burgeoning business of Bausch & Lomb Preservision / multivitamins 90.6 9.3 5.2 0.2 3.6 4.3 adult gummy vitamins, for Centrum / multivitamins 76.3 8.6 4.4 0.1 7.0 10.7 example, Pharmavite re- One A Day Vita Craves / multivitamins 73.5 16.5 4.3 0.4 7.0 14.4 cently expanded Align / mineral supplements 71.0 7.9 2.1 0.1 2.2 6.0 its Nature Made Adult Gum- Culturelle / mineral supplements 66.9 45.2 2.0 0.6 3.3 48.1 mies product Caltrate / mineral supplements 64.2 -10.0 1.9 -0.3 5.5 -9.9 line with a Citracal / mineral supplements 63.6 -14.9 1.9 -0.4 5.2 -15.2 Multi + Ome- Bausch & Lomb Ocuvite / multivitamins 63.0 28.7 3.6 0.6 4.8 26.5 ga-3, an En- Sundown Naturals / 1 & 2 letter vitamins 59.2 13.0 5.7 0.4 9.0 9.4 ergy B12 and Immune Com- Phillips Colon Health / mineral supplements 58.2 9.8 1.8 0.1 3.2 4.9

plex with Zinc. * In millions Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. Multi-Outlet (supermarkets, ** Percent share of segment drug stores, mass market retailers, military commissaries and select club and dollar retail chains)

34 • march 17, 2014 DrugStoreNews.com OTC Buyer’s guide

Sleep remedies Sleep aids awaken Top 10 brands Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** There is a reason retailers raised the pro- file on sleep with Procter & Gamble’s intro- Vicks Nyquil ZzzQuil / liquids $74.4 105.7% 74.0% 2.9% duction of Vicks’ ZzzQuil. In fact, there are Vicks Nyquil ZzzQuil / tablets 48.6 76.4 15.7 5.9 123 million reasons — that’s how much the brands generated across tablets and liquids Unisom SleepGels / tablets 29.3 11.9 9.5 0.2 in 2013. Sleep aid shots, the antithesis to en- Alteril / tablets 15.7 -19.1 5.1 -1.8 ergy shots, also are performing well with up-and-comers, including Dream Products’ Midnite / tablets 14.5 -11.6 4.7 -1.1 Dream Water and Neuro’s Neuro Sleep. Unisom SleepTabs / tablets 13.9 0.2 4.5 -0.4 by the channel Nature Made Sleep / tablets 6.6 -27.4 2.1 -1.1 Multi-Outlet* % Chg Drug % Chg Dream Water / liquids 6.4 14.3 6.3 -4.6 Sleeping aid tablets $309.5 9.7% $114.7 7.9% Neuro Sleep / liquids 6.3 15.6 6.3 -4.5 Sleeping aid liquids 100.4 97.5 33.6 95.6 Sominex / tablets 4.5 -18.8 1.5 -0.5 Total $409.9 NA $148.3 NA * Supermarkets, drug stores, mass market retailers, military commissaries and select * In millions ** Percent share of segment club and dollar retail chains Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. Multi-Outlet (supermarkets, Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions drug stores, mass market retailers, military commissaries and select club and dollar retail chains) Looking for national distribution? National Sales Solutions is a leading sales and marketing management company specializing in health and beauty care products.

Partner with us for national distribution and a complete range of services and support to help you succeed.

• Market and competitive brand analysis • Consumer and in-store marketing and sales strategy • Financial modeling; forecasting/budgeting • Five regional sales management offices Call for a free 15 minute • National broker network covering all food, drug and mass retailers product evaluation. • Customized sales presentations

Contact Ron Otto at [email protected] or (636)-527-7115 for initial brand review and cost estimates. Partners include: Ron Otto • Jim Lewis • Tom Fraley • Chuck Robinson • Rich Siporin www.nationalsalessolutions.com

NSSDSN36 halfpage• march 2014.indd 17, 2014 1 DrugStoreNew2/14/14s.com 4:55 PM

Untitled-29 1 2/28/14 2:08 PM OTC Buyer’s guide

Smoking cessation Promoting health through clinical programs

Smoking cessation is one of the key clinical opportunities for re- Top brands tail pharmacy to showcase its value to overall health care, as evidenced by CVS/pharmacy’s decision to exit the tobacco business. Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Category captain GlaxoSmithKline has been partnering with retailers on the launch of branded smoking-cessation programs with Nicorette / gum $220.1 2.4% 45.7% 0.7% partnerships with both Walgreens and Walmart having been an- Nicorette / tablets 73.5 -10.7 32.8 -5.2 nounced in the past two months. Nicoderm CQ / patch 63.9 -8.8 39.3 -1.4 by the channel Habitrol / patch 1.9 -16.7 1.2 -0.2 Multi-Outlet* % Chg Drug % Chg Rexall / gum 1.4 92.8 0.3 0.1 Anti-smoking gum $481.5 0.8% $203.6 -1.5% Rugby / patch 0.2 NA 0.1 0.1 Anti-smoking tablets 224.0 3.6 91.4 -0.1 Rugby / gum 0.1 -15.4 0.0 0.0 Anti-smoking patch 162.6 -5.4 76.0 -6.3 Zonnic / gum 0.1 781.9 0.0 0.0 Total $868.1 NA $371.0 NA

* Supermarkets, drug stores, mass market retailers, military commissaries and select * In millions ** Percent share of segment club and dollar retail chains Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. Multi-Outlet (supermarkets, Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions drug stores, mass market retailers, military commissaries and select club and dollar retail chains)

Tecnu® has a new look!

Tecnu has been the trusted name in poison ivy and oak for decades. With products to remove the rash causing oil, effectively relieve itching, and dry up the oozing rash, Tecnu has the solution for you.

Request coupons and samples for your pharmacy! Visit http://www.teclabsinc.com/pharmacist_tecnu or email [email protected] teclabs.com 800-482-4464

March 38DSNad_0114.indd • march 417, 2014 DrugStoreNew1/28/14s.com 2:14 PM

Untitled-29 1 2/28/14 2:13 PM OTC Buyer’s guide

weight loss

Top 10 brands† Diet aids gain Brand / segment Sales* % Sales Chg $ Share** $ Share Chg** Adult nutrition and meal replacement bars dominate the diet-aid Ensure / liquid/powder $343.5 6.5% 13.2% 0.1% sector with Abbott Nutrition’s Ensure RTD shakes and General Mills’ 5 Hour Energy SS / energy shot 331.6 -11.8 85.7 -0.3 Fiber One bars. And though no diet-aid tablet cracked the top 10 brand General Mills Fiber One / 305.4 25.2 15.7 1.5 list, GlaxoSmithKline’s return to market of Alli is a significant contrib- nutr/intrinsic health value bars utor to overall growth of 16.6% across weight control tablets. Pedia Sure / liquid/powder 223.9 0.7 8.6 -0.4 Clif / nutritional/intrinsic by the channel 215.8 17.9 11.1 0.4 health value bars Multi-Outlet* % Chg Drug % Chg Boost / liquid/powder 184.7 4.4 7.1 -0.1 Weight control/ $2,604.0 5.5% $287.2 7.5% nutritionals liquid/powder Ensure Plus / liquid/powder 151.7 7.6 5.8 0.1 Nutritional/intrinsic health Slim Fast 321 Plan / liq/pwdr 140.0 -11.5 5.4 -1.0 1,942.8 13.5 100.5 6.2 value bars Nature Valley Protein / 127.4 33.1 6.6 1.0 nutr/intrinsic health value bars Weight control candy/tablets 503.8 16.6 150.0 8.2 Atkins Advantage / Energy shots 386.8 -11.5 73.0 -18.3 124.1 23.5 6.4 0.5 nutr/intrinsic health value bars Total $5,437.4 NA $610.7 NA † Includes weight control/nutrition liquid/powder, weight control candy/tablets, energy shots, * Supermarkets, drug stores, mass market retailers, military commissaries and nutritional/intrinsic health value bars * In millions **Percent share of segment select club and dollar retail chains Source: IRI for the 52 weeks ended Dec. 29, 2013, Total U.S. Multi-Outlet (supermarkets, Source: SymphonyIRI Group for the 52 weeks ended Dec. 29, 2013, in millions drug stores, mass market retailers, military commissaries and select club and dollar retail chains) Affordable, Effective, Non-toxic Head Lice Treatment Licefreee Spray!® Instant Head Lice Treatment is changing the way parents conquer head lice. A recent preliminary 40-subject clinical study* suggests that homeopathic BenefitS of Licefreee Spray! is an effective alternative to traditional LicefReee SpRay incLude: OTC chemical pesticide treatments. Effective at killing lice AND their nits Affordable, over-the-counter treatment Fast & easy to use Safe for children 6 months & older Non-toxic, does not use permethrin or pyrethrum Available at local retailers such as Walgreens, Walmart & Dollar General

Request a sample and bilingual patient guides! Visit http://www.teclabsinc.com/pharmacist_licefreee or email [email protected]

teclabs.com 800-482-4464 *Pharmacology & Pharmacy, 2013, 4, 266-273 doi:10.4236/pp.2013.42038 Published Online April 2013 (http://www.scirp.org/journal/pp)

March DSNad_0114.indd 1 1/30/14 3:08 PM 40 • march 17, 2014 DrugStoreNews.com

Untitled-29 1 2/28/14 2:11 PM OTC product listing

Acura Pharmaceuticals Address: 616 N. North Court, Suite 120, Palatine, Ill., 60067 Website: AcuraPharm.com Phone: (847) 705-7709 Email: [email protected]

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company developing commonly known as meth. and commercializing tamper-resistant products to combat medication abuse and Nexafed temporarily relieves misuse. For a decade, Acura has been on the forefront of developing solutions to nasal congestion due to the common combat this epidemic, with products utilizing the company’s proprietary abuse deter- cold, hay fever or other upper respiratory allergies. Nexafed also rent Aversion® and Impede® Technologies. helps to decongest sinus openings and passages to temporarily relieve sinus conges- Nexafed is Acura’s next generation, maximum strength, non-drowsy pseudoephed- tion and pressure. rine hydrochloride (HCl) non-prescription medication that combines effective nasal Nexafed® is the only meth-resistant pseudoephedrine product that meets FDA and sinus congestion relief with methamphetamine-resistant Impede® technology.* standards demonstrating therapeutic equivalence to the other commonly used pseu- Impede is a combination of safe inactive ingredients that significantly disrupts the doephedrine products, such as Sudafed® (registered trademark of Johnson & John- conversion of pseudoephedrine into the dangerous illegal drug methamphetamine, son).* No other meth-resistant product meets these standards.

* Brzeczko, A. et al. The advent of a new pseudoephedrine product to combat methamphetamine abuse. American Journal of Drug and Alcohol Abuse. September 2013, Vol. 39, No. 5, Pages 284-29. http://informahealthcare.com/doi/abs/10.3109/00952990.2013.821476.

Alcon Address: 6201 South Fwy, Fort Worth, Texas 76134-2001 Website: ClearCareSolution.com or Alcon.com Phone: (800) TO-ALCON Email: [email protected] or [email protected]

Alcon, the global leader in eye care, provides innovative products that enhance qual- bacteria for strong disinfection and deep ity of life by helping people worldwide see better. One of these innovative products is cleaning. After the hydrogen peroxide CLEAR CARE® Solution, a unique, patented formulation that makes contact lenses feel provides deep cleaning, a built-in cleaning like new after each cleaning. agent loosens dirt, debris and deposits. Finally, CLEAR CARE® has a unique Triple Action Cleaning process that you can see working, bubbling action enhances surface protein re- different from multipurpose solutions. CLEAR CARE® has no added preservatives that moval, leaving lenses feeling fresh, clean and may irritate eyes. It uses hydrogen peroxide to penetrate the lens, and kills germs and more comfortable.

Boehringer Ingelheim

Address: 900 Ridgebury Rd., Ridgefield, Conn., 06877-0368 Website: Boehringer-Ingelheim.com Phone: (203) 798-4111 Email: [email protected]

As a 125-year-old privately held, family-owned company, Boehringer Ingelheim has health. Boehringer Ingelheim’s consumer division is dedicated to bringing branded OTC remained focused on furthering science to benefit the health of patients and their fami- products to market, including Zantac for heartburn prevention and relief, and Dulcolax lies. Our privately held status allows us to focus on research and development. We’re for constipation relief. In 2014, DulcoGas was launched to offer gas relief in minutes. researching to address more than 22 chronic conditions and have successfully launched Boehringer Ingelheim has a long heritage of doing the right thing — for our patients more than 12 major products in the past decade, with several more therapies in and their families, communities, customers and employees. We recognize that we are our pipeline. part of a larger community, and our family of employees feels strongly about partnering Boehringer Ingelheim’s U.S. Consumer Healthcare portfolio promotes overall GI with organizations to improve it.

42 • march 17, 2014 DrugStoreNews.com OTC product listing

Fleet Laboratories Address: 4615 Murray Place, Lynchburg, Va., 24502 Website: CBCFleet.com Phone: (434) 522-8409 Email: [email protected]

Fleet Laboratories has been manufacturing and selling products that meet the needs Our newest product will launch in the spring of 2014: of our consumers for almost 150 years. Strategically, Fleet Laboratories is focused on Maximum Strength Phazyme 250-mg. This product inno- growing our business within our three core segments: feminine care, gastrointestinal care vation will deliver the highest dose of the active ingredient and infant care. Our renowned brand portfolio includes the top-selling brand in the femi- simethicone permitted under the monograph and repre- nine hygiene category, Summer’s Eve®; baby care brand, Boudreaux’s Butt Paste®; and sents the first increased dose of simethicone delivered to gastrointestinal brands, Fleet® for adults, Pedia-Lax® for children and our newest brand — the OTC market in almost 15 years. No product on the mar- Phazyme® anti-gas. Through our extensive distributor network, our products are available ket will deliver a higher single dose of simethicone, the active ingredient recommended in more than 85 countries across the globe. most by physicians and pharmacists for relief of gas.

Gordon Brush

Address: 6247 Randolph St., Commerce, Calif., 90040 Website: FootMate.com Phone: (323) 450-2748 Email: [email protected]

Foot care is a daily challenge, but the podiatrist-recommended FootMate® Sys- product is great for anyone wanting a soothing, tem makes optimal foot health easy. It is a complete foot care system for cleaning, stimulating way to clean and massage their feet in soothing, stimulating and massaging your feet every time you shower. the shower. The FootMate® System is a brush and specially formulated gel that goes in the The FootMate® System is the ultimate foot massage and the perfect way to pam- bath or shower to clean and massage your feet without having to bend over. The per your tired, aching feet. Refresh, Restore, Renew!™

National Sales Solutions Calorease Address: 113 Old State Rd., Suite 104, Ellisville, Mo., 63021 Address: 187 E. Warm Springs Rd., Suite B 196, Las Vegas, Nev., 89119 Website: NationalSalesSolutions.com and RetailSmarter.com Website: Calorease.com Phone: (636) 527-7115 Phone: (800) 780-3132 Email: [email protected] Email: [email protected]

National Sales Solutions, or NSS, is a leading provider of outsourced sales manage- Introducing Calorease with FBCx ment. We help clients launch new products, expand into new retailers, grow current sales — a stimulant-free, heart-healthy or enter the U.S. market from abroad. NSS serves most CPG retail channels, including weight-management aid. The ac- food, drug, mass, convenience, beauty, natural products, and major online retailers. NSS tive ingredient, “super fiber” FBCx, has a 20-year history of excellence in client service and integrity in business. binds to up to nine times its weight Through a strategic alliance with Retail Smarter, LLC, National Sales Solutions now in dietary fat, safely removing offers a full CPG solution — sales, marketing and supply chain. Retail Smarter provides it from the body before it can trade marketing expertise, such as market analysis, sales strategy and retailer commu- be absorbed. That’s equivalent nication. On the consumer marketing side, Retail Smarter specializes in cost-effective to removing up to 500 calories of fat from your brand-building, including advertising and media planning. With experience in warehous- daily food intake, or up to 15,000 calories per month, which could be a whole ing, transportation and all aspects of supply-chain management, Retail Smarter helps pants size! Naturally sourced and clinically researched, Calorease with FBCx gives client brands operate more efficiently. Together, NSS and Retail Smarter offer a one-of-a- you the extra edge in your weight-management plan, without the restrictions of a kind solution for turnkey business growth. low-fat diet.

44 • march 17, 2014 DrugStoreNews.com Tec Labs Address: 7100 Tec Labs Way SW, Albany, Ore., 97321 Website: TecLabsInc.com Phone: (800) ITCHING Email: [email protected]

Tec Laboratories, Inc. is a family-owned and -operated OTC pharmaceutical manu- and easy to use, just spray the treatment onto the facturer that has been specializing in innovative topical applications since 1962. More hair and scalp to saturate, and it begins killing lice than a decade ago, Tec Labs broke new ground and launched the first non-toxic head and nits on contact. lice solution, Licefreee!® Gel. Today, the Licefreee brand is the trusted solution to end Clinically shown to kill lice and nits, combing is head lice infestation by parents, school nurses and school administrators. not required to become lice-free. However, a profes- In the spirit of innovation, in 2008 Tec Labs launched Licefreee Spray!® Instant sional nit comb is included for children that attend Head Lice Treatment. This new solution for head lice is transforming the way we treat schools requiring the complete removal of nits before head lice infestation by effectively killing lice and nits without the use of chemical returning to class. pesticides or hours of combing. Here to help you end head lice and get your chil- Licefreee Spray! kills lice and nits naturally using a homeopathic solution that con- dren back to school, Licefreee Spray! gets the job tains sodium chloride, more commonly known as salt. The no-rinse formula is fast done unlike any other treatment on the shelf.

Tec Labs Address: 7100 Tec Labs Way SW, Albany, Ore., 97321 Website: TecLabsInc.com Phone: (800) ITCHING Email: [email protected]

In 1962, the invention of Tecnu® Original Outdoor Skin Cleanser changed the The trusted name in outdoor solutions since way outdoor professionals and enthusiasts tackle poison oak, ivy and sumac. De- 1962, Tecnu is a must-have in your first aid signed to unlock and remove urushiol oil that causes your rash, Tecnu Original is kit, medicine cabinet or backpack. With Tecnu, a waterless cleanser that proves convenient outdoors, where a water source may you can keep the adventure going and continue not be readily available. Simply apply, rub vigorously for two minutes, and wipe off. living your life outdoors!

Wahl Clipper Address: 2900 N. Locust St., Sterling, Ill., 61081 Website: HomeProducts.Wahl.com Phone: (800) 767-9245 Email: [email protected]

Since 1919, with the invention of the first practical electric hair clipper, Wahl of grooming products to our category revi- Clipper has been the leader in the professional, home, pet grooming and massager talization of therapeutic massagers to categories. Still family-owned, we have more than 2,200 employees worldwide that our fastest selling all-natural dog carry forward the tradition of innovation and superior customer service. Our prod- shampoo line, Wahl has proven ucts are sold in more than 165 countries worldwide, with eight global manufactur- again and again that retailers can ing facilities. As a vertically integrated manufacturer, we control the product quality count on Wahl to grow categories. from inception through customer satisfaction. We do not believe in outsourcing our Ask us about our new Elite Clipper, manufacturing or customer service onto third parties. As leaders in innovation for 95 which brings innovation and excitement years, Wahl continues its leadership. From our first-to-the-market Lithium ion line to the hair-cutting category.

DrugStoreNews.com march 17, 2014 • 45